Suscribirse

Severe methicillin-susceptible Staphylococcus aureus infections associated with epidural injections at an outpatient pain clinic - 29/02/12

Doi : 10.1016/j.ajic.2011.03.007 
Rachel Radcliffe, DVM, MPH a, b, , Elissa Meites, MD, MPH a, c, Janet Briscoe, RN, BSN, MBA d, Rahul Gupta, MD, MPH, FACP d, e, f, Gregory Fosheim, MPH c, Sigrid K. McAllister, BS, MT (ASCP) c, Bette Jensen, MMSc c, Judith Noble-Wang, PhD c, Maria del Rosario, MD, MPH b, Jeff Hageman, MHS c, Priti R. Patel, MD, MPH c
a Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA 
b Division of Infectious Disease Epidemiology, West Virginia Department of Health and Human Resources, Charleston, WV 
c Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 
d Kanawha-Charleston Health Department, University of Charleston, Charleston, WV 
e Department of Academic Affairs, School of Pharmacy, University of Charleston, Charleston, WV 
f Department of Medicine, West Virginia University School of Medicine, Morgantown, WV 

Address correspondence to Rachel Radcliffe, DVM, MPH, West Virginia Department of Health and Human Resources, Division of Infectious Disease Epidemiology, 350 Capitol St, Room 125, Charleston, WV 25301.

Abstract

Background

Recent outbreaks in ambulatory care settings have highlighted infection control breaches as risk factors for disease transmission. In May 2009, 3 patients were hospitalized with severe methicillin-susceptible Staphylococcus aureus (MSSA) infections after receiving epidural injections at a West Virginia outpatient pain clinic.

Methods

We conducted a retrospective cohort study evaluating clinic patients who received injections during a 3-week period. A case was defined as laboratory-confirmed infection or clinical evidence of infection ≤ 14 days after a patient received an injection. Infection control procedures were assessed. MSSA isolates from patient infections and clinic staff nasal swabs were genotyped by using pulsed-field gel electrophoresis.

Results

Eight (7%) of 110 cohort patients met the case definition; 6 (75%) cases were laboratory confirmed. Eight (12%) of 69 patients who received epidural injections were case patients compared with none of the other 41 patients (P = .02). During procedures, staff use of face masks and preparation of patient skin were suboptimal; epidural injection syringes were reused to access shared medication vials. MSSA isolates from 2 patients and 1 staff member were indistinguishable by pulsed-field gel electrophoresis.

Conclusion

Infection control breaches likely facilitated MSSA transmission to patients receiving epidural injections. Adhering to correct infection control practices in ambulatory care settings is critical to prevent disease transmission.

El texto completo de este artículo está disponible en PDF.

Key Words : Staphylococcus aureus, Pain clinic, Outbreak, Epidural injection


Esquema


 The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
 Conflicts of interest: None to report.


© 2012  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 40 - N° 2

P. 144-149 - mars 2012 Regresar al número
Artículo precedente Artículo precedente
  • The associations between organizational culture and knowledge, attitudes, and practices in a multicenter Veterans Affairs quality improvement initiative to prevent methicillin-resistant Staphylococcus aureus
  • Ronda L. Sinkowitz-Cochran, Kelly H. Burkitt, Timothy Cuerdon, Cassandra Harrison, Shasha Gao, D. Scott Obrosky, Rajiv Jain, Michael J. Fine, John A. Jernigan
| Artículo siguiente Artículo siguiente
  • Identifying the gaps in infection prevention and control resources for long-term care facilities in British Columbia
  • Bruce Gamage, Valerie Schall, Jennifer Grant, PICNet Long-term Care Needs Assessment Working Group

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.